Artificial Intelligence In Clinical Decision Support Market Report 2026

Artificial Intelligence In Clinical Decision Support Market Overview

• Artificial Intelligence In Clinical Decision Support market size has reached to $0.96 billion in 2025 • Expected to grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 17.1% • Growth Driver: Increasing Adoption Of Precision Medicine Approaches Driving The Growth Of The Market Through Expanding Genomic Data Integration • Market Trend: Integration Of Generative AI Into Clinical Decision Support Improving Diagnostic Efficiency And Personalized Care Delivery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence In Clinical Decision Support Market?

Artificial intelligence in clinical decision support (CDS) refers to the use of artificial intelligence technologies, including machine learning, natural language processing, and predictive analytics, to assist healthcare professionals in making accurate and evidence-based clinical decisions. It enables the analysis of patient data, medical histories, diagnostic information, and treatment guidelines to improve diagnosis accuracy, treatment planning, patient monitoring, and overall healthcare outcomes. The main components of artificial intelligence in clinical decision support include software and services. Software refers to AI driven clinical platforms designed to analyze patient data and assist healthcare professionals in making accurate clinical decisions. These solutions are delivered through cloud based solutions, hybrid solutions and on-premises solutions. The various applications involved are diagnostic decision support, therapeutic decision support, and medication management, and they are used by several end uses such as pharmaceutical and biotechnology companies, hospitals, and physician practices and ambulatory clinics.

What Is The Artificial Intelligence In Clinical Decision Support Market Growth Forecast?

The artificial intelligence in clinical decision support market size is expected to see rapid growth in the next few years. It will grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to widespread adoption of real time clinical analytics, expansion of interoperable healthcare data ecosystems, increasing demand for personalized medicine support tools, rising focus on clinical safety and decision transparency, integration of multimodal patient data for precision diagnostics. Major trends in the forecast period include interoperable clinical data exchange frameworks, real world evidence driven clinical validation systems, clinician workflow integration and automation tools, patient centric personalized treatment recommendation systems, regulatory compliant clinical decision audit and documentation systems.

Global Artificial Intelligence In Clinical Decision Support Market Segmentation

1) By Component: Software; Services 2) By Delivery Model: Cloud Based Solutions; Hybrid Solutions; On-Premises Solutions 3) By Application: Diagnostic Decision Support; Therapeutic Decision Support; Medication Management 4) By End Use: Pharmaceutical And Biotechnology Companies; Hospitals; Physician Practices And Ambulatory Clinics Subsegments: 1) By Software: Clinical Decision Support Platforms; Predictive Analytics Software; Diagnostic Support Systems; Treatment Recommendation Systems 2) By Services: Implementation And Integration Services; Consulting Services; Managed Services; Maintenance And Support Services

What Is The Driver Of The Artificial Intelligence In Clinical Decision Support Market?

The increasing adoption of precision medicine approaches is expected to propel the growth of the artificial intelligence in clinical decision support market going forward. Precision medicine is a healthcare approach that customizes disease prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environmental factors. The adoption of precision medicine approaches is increasing due to the rapid expansion of genomic research and the growing availability of large-scale patient data. Artificial intelligence in clinical decision support helps precision medicine approaches by analyzing complex genomic and clinical datasets to deliver personalized treatment recommendations, improve diagnostic accuracy, and enhance predictive healthcare outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, an increase from the six approved in 2022. Therefore, the increasing adoption of precision medicine approaches is driving the growth of the artificial intelligence in clinical decision support industry.

Key Players In The Global Artificial Intelligence In Clinical Decision Support Market

Major companies operating in the artificial intelligence in clinical decision support market are International Business Machines Corporation; Oracle Corporation; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; McKesson Corporation; Siemens Healthineers AG; Wolters Kluwer N.V.; Becton Dickinson and Company; Veradigm Inc.; NextGen Healthcare Inc.; Merative L.P.; Athenahealth Inc.; Agfa-Gevaert N.V.; Premier Inc.; Aidoc Medical Ltd.; Viz.ai Inc.; Persyst Development Corporation; Etiometry Inc.; BeeKeeperAI Inc.; Natus Medical Incorporated; Nuance Communications Inc.; Epic Systems Corporation; Medical Information Technology Inc. (MEDITECH); Enlitic Inc.; Qventus Inc.

Global Artificial Intelligence In Clinical Decision Support Market Trends and Insights

Major companies operating in the artificial intelligence in clinical decision support market are focusing on integration of generative AI into clinical decision support, such as large language model-based healthcare assistants, to improve clinical workflow efficiency, automate medical documentation, and enhance personalized treatment recommendations. Large language model-based healthcare assistants are generative AI systems trained on extensive medical and clinical datasets that support healthcare professionals by interpreting patient information, generating clinical summaries, and delivering evidence-based recommendations in real time. For instance, in October 2024, Microsoft Corporation, a US-based technology company, introduced Copilot for Healthcare, a generative AI-powered healthcare solution designed to streamline administrative and clinical processes. The solution integrates with electronic health records to generate clinical summaries, supports natural language voice dictation for medical documentation, and enables clinicians to access real-time medical insights through conversational AI capabilities.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Clinical Decision Support Market?

In October 2024, VitalHub Corp., a Canada-based healthcare technology company, acquired MedCurrent Corporation for an undisclosed amount. With this acquisition, VitalHub aimed to strengthen its clinical decision support capabilities and expand its healthcare software portfolio by integrating MedCurrent’s evidence-based imaging order support solutions into its platform offerings. MedCurrent Corporation is a Canada-based provider of clinical decision support solutions focused on improving the appropriateness of diagnostic imaging orders.

Regional Outlook

North America was the largest region in the artificial intelligence in clinical decision support market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence In Clinical Decision Support Market?

The artificial intelligence in clinical decision support market includes revenues earned by entities by providing services such as predictive analytics, treatment recommendation systems, patient risk assessment, workflow optimization, and clinical data management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence In Clinical Decision Support Market Report 2026?

The artificial intelligence in clinical decision support market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in clinical decision support industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.